Nav: Home

ACS announces new open-access journal ACS Omega

December 14, 2015

The Publications Division of the American Chemical Society (ACS) will expand its open access program in 2016 with today's announcement of ACS Omega, a new open access, multidisciplinary chemistry journal publishing peer-reviewed research of broad impact from around the world. The Society made the announcement at the opening of Pacifichem, the international chemistry conference co-organized by the ACS, which is taking place in Hawaii this week.

Authors who publish their research in ACS Omega will benefit from rapid editorial decisions, swift publication and immediate availability to the global scientific community and general public. ACS Omega will publish articles on the basis of rigorous technical review rather than subjective editorial or reviewer opinions of the work's significance or impact. The journal will satisfy open access mandates from a range of funders and provide an authoritative home for original research articles of scientific value covering all areas of chemistry, chemical engineering and allied scientific fields.

The global reach of ACS Omega is underscored by its editorial structure, which is unique to ACS' preeminent portfolio of peer-reviewed journals. ACS has collectively published more than 46,000 papers from China, India and Korea over the past five years, with an abundance of new and groundbreaking research coming from these emerging markets. With an eye on achieving a globally diverse journal, four co-editors, who will be based in China, India, Europe and the Americas, will establish and lead the editorial vision for the journal. The editors will draw on a geographically diverse editorial board composed of active scientists with distinct chemical expertise and scientific backgrounds.

ACS Omega will provide an attractive new opportunity for authors to publish with the ACS. The Society currently publishes more than 40,000 peer-reviewed articles annually across all of its journals, but tens of thousands of manuscripts are declined each year by journal editors. ACS Omega will provide an appealing venue for all articles that are deemed scientifically sound, which will spare many authors the tedium of reformatting their manuscripts and undergoing additional rounds of peer review.

Brian Crawford, Ph.D., president of ACS Publications, says, "We are thrilled to announce the launch of ACS Omega. This journal will serve a broad global community of researchers who are seeking swift evaluation and publication of their work, including authors and readers from around the world who are eager to see their work featured by the ACS as a major scientific society publisher."

Crawford adds, "We are introducing an agile and seamless manuscript transfer system that will enable authors submitting to one ACS journal to be easily referred for review and publication in another suitable ACS journal, should their paper not be accepted by their first-choice forum. ACS Omega will be an important component of that manuscript transfer system."

ACS Omega will begin accepting research submissions in the spring of 2016 and will publish its first articles online that summer. It will set article publishing charges competitive with other open access journals that feature objective peer review.

The name ACS Omega is an evocative reference to the "megajournal" term that is frequently associated with journals offering objective peer review. It also signals the journal's open access publishing strategy and is a name that scientists around the world will immediately recognize.

ACS Omega is the latest addition to the Society's comprehensive and far-reaching open access program. The new journal joins sister publication ACS Central Science, ACS' first fully open access, highly selective journal, which published its first issue in April 2015. The Society's open access program also includes ACS Author Rewards, a stimulus program to encourage authors to publish their work as open access; ACS Editors' Choice, a service whereby ACS editors select and openly feature one new article per day of broad public interest; and ACS AuthorChoice, a program that provides authors flexible open access license options that acknowledge funders' open access requirements and offers ACS Certified Deposit -- deposition by ACS of the final published article to an institutional or funder repository of the authors' designation.
-end-
About ACS Publications

ACS Publications, a division of the American Chemical Society, is a nonprofit scholarly publisher of nearly 50 peer-reviewed journals and a range of eBooks at the interface of chemistry and allied sciences, including physics and biology. ACS Publications journals are among the most cited, most trusted and most read within the scientific literature. Respected for their editorial rigor, ACS journals offer high quality service to authors and readers, including rapid time to publication, a range of channels for researchers to access the Society's cutting-edge Web and mobile delivery platforms and a comprehensive program of open access options for authors and their funders. ACS Publications also publishes Chemical & Engineering News -- the Society's newsmagazine covering science and technology, business and industry, government and policy, education and employment aspects of the chemistry field.

The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 158,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.

To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org.

Follow us: TwitterFacebook

American Chemical Society

Related Chemistry Articles:

Coordination chemistry and Alzheimer's disease
It has become evident recently that the interactions between copper and amyloid-β neurotoxically impact the brain of patients with Alzheimer's disease.
Can ionic liquids transform chemistry?
Table salt is a commonplace ingredient in the kitchen, but a different kind of salt is at the forefront of chemistry innovation.
Principles for a green chemistry future
A team led by researchers from the Yale School of Forestry & Environmental Studies recently authored a paper featured in Science that outlines how green chemistry is essential for a sustainable future.
Sugar changes the chemistry of your brain
The idea of food addiction is a very controversial topic among scientists.
Reflecting on the year in chemistry
A lot can happen in a year, especially when it comes to science.
Better chemistry through tiny antennae
A research team at The University of Tokyo has developed a new method for actively controlling the breaking of chemical bonds by shining infrared lasers on tiny antennae.
Chemistry in motion
For the first time, researchers have managed to view previously inaccessible details of certain chemical processes.
Researchers enrich silver chemistry
Researchers from Russia and Saudi Arabia have proposed an efficient method for obtaining fundamental data necessary for understanding chemical and physical processes involving substances in the gaseous state.
The chemistry behind kibble (video)
Have you ever thought about how strange it is that dogs eat these dry, weird-smelling bits of food for their entire lives and never get sick of them?
Top 10 chemistry start-ups
Starting a new chemistry-based company is one part discovery, one part risk.
More Chemistry News and Chemistry Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Teaching For Better Humans 2.0
More than test scores or good grades–what do kids need for the future? This hour, TED speakers explore how to help children grow into better humans, both during and after this time of crisis. Guests include educators Richard Culatta and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Dispatch 3: Shared Immunity
More than a million people have caught Covid-19, and tens of thousands have died. But thousands more have survived and recovered. A week or so ago (aka, what feels like ten years in corona time) producer Molly Webster learned that many of those survivors possess a kind of superpower: antibodies trained to fight the virus. Not only that, they might be able to pass this power on to the people who are sick with corona, and still in the fight. Today we have the story of an experimental treatment that's popping up all over the country: convalescent plasma transfusion, a century-old procedure that some say may become one of our best weapons against this devastating, new disease.   If you have recovered from Covid-19 and want to donate plasma, national and local donation registries are gearing up to collect blood.  To sign up with the American Red Cross, a national organization that works in local communities, head here.  To find out more about the The National COVID-19 Convalescent Plasma Project, which we spoke about in our episode, including information on clinical trials or plasma donation projects in your community, go here.  And if you are in the greater New York City area, and want to donate convalescent plasma, head over to the New York Blood Center to sign up. Or, register with specific NYC hospitals here.   If you are sick with Covid-19, and are interested in participating in a clinical trial, or are looking for a plasma donor match, check in with your local hospital, university, or blood center for more; you can also find more information on trials at The National COVID-19 Convalescent Plasma Project. And lastly, Tatiana Prowell's tweet that tipped us off is here. This episode was reported by Molly Webster and produced by Pat Walters. Special thanks to Drs. Evan Bloch and Tim Byun, as well as the Albert Einstein College of Medicine.  Support Radiolab today at Radiolab.org/donate.